IP Library Granted Patent US 10,603,210
Granted Patent B1
US 10,603,210 · App. 15/887,406 · Granted Mar 31, 2020

Meibomian gland probing with blood product injection

Inventor: Steven L. Maskin (Tampa, FL)
Assignee: MGD INNOVATIONS, LLC
A61F9/00736A61F9/0008A61M31/00A61K9/0048A61M25/007A61M2202/0413A61M2202/0415A61M2202/0423A61M2202/0427A61M2202/0462A61M2210/0612
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,603,210
App. No.
15/887,406
Granted
Mar 31, 2020
Kind
B1
Abstract

A method of improving meibomian gland function in a patient includes inserting a cannula into an interior of a meibomian gland of the patient through an orifice thereinto, the cannula including at least one opening in communication with the interior of the meibomian gland, and injecting a blood product into the interior of the meibomian gland through the inserted cannula via the at least one opening.

Claims (24)

1. A method of improving meibomian gland function in a patient, the method comprising:

inserting a cannula into an interior of a meibomian gland of the patient through an orifice thereinto, the cannula including at least one opening in communication with the interior of the meibomian gland; and

injecting a blood product into the interior of the meibomian gland through the inserted cannula via the at least one opening.

2. The method of claim 1 , further comprising inserting at least one probe into the interior of the meibomian gland through the orifice prior to insertion of the cannula.

3. The method of claim 2 , wherein inserting the at least one probe prior to insertion of the cannula includes inserting at least two probes of differing lengths prior to insertion of the cannula.

4. The method of claim 3 , wherein inserting the at least two probes of differing lengths includes:

first, inserting a 1-millimeter (mm) long probe;

second, inserting a 2-mm long probe; and

third, inserting a 4-mm long probe to a full length of the meibomian gland.

5. The method of claim 1 , wherein injecting the blood product includes injecting autologous serum (AS).

6. The method of claim 5 , wherein the AS is obtained using venipuncture.

7. The method of claim 5 , wherein the AS is obtained using a finger prick.

8. The method of claim 5 , wherein the AS is 50% AS.

9. The method of claim 1 , wherein injecting the blood product includes injecting at least one of the following blood-derived sera:

allogenic serum;

umbilical cord serum; and

recombinant serum.

10. The method of claim 1 , wherein injecting the blood product includes injecting at least one of the following platelet preparations:

platelet rich plasma;

platelet lysate;

platelet releasate; and

platelet concentrate.

11. The method of claim 1 , wherein injecting the blood product includes injecting fresh frozen plasma.

12. The method of claim 1 , wherein injecting the blood product includes injecting at least one of albumin and fibronectin.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded May 13, 2020
From: MGD INNOVATIONS LLC; MGD INNOVATIONS, INC.
To: MGD INNOVATIONS, INC.
Reel/Frame 052653/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2018
From: MASKIN, STEVEN L.
To: MGD INNOVATIONS, LLC
Reel/Frame 044844/0741 →
Continuity (1)
Provisional Application 62453804 · Feb 2, 2017